Patients Demonstrated Good Medication Adherence While Taking Biosimilar Treatment
FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis
Biologics May Prevent Cardiovascular Events in RA Patients
Study Finds Mirikizumab Superior to Secukinumab for Plaque Psoriasis
FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
Biosimilar Prescribing Habits in the VA & Academic Settings
Biosimilars Are Slowly Climbing Toward Acceptance in Rheumatology
U.S. Insurers Often Limit Biosimilar Coverage
Rheumatology Biologic Expertise Valued for COVID-19 Treatment Decisions
- 1
- 2
- 3
- …
- 32
- Next Page »